SynopsisGlatiramer is an immunomodulator medication currently used to treat multiple sclerosis. The global Glatiramer market was valued at US$ 1072 million in 2023 and is anticipated to reach US$ 597.1 million by 2030, witnessing a CAGR of -6.8% during the forec.....
SynopsisGlatiramer is an immunomodulator medication currently used to treat multiple sclerosis. The global Glatiramer Drugs market was valued at US$ 1072 million in 2023 and is anticipated to reach US$ 597.1 million by 2030, witnessing a CAGR of -6.8% during the.....
SynopsisGlatiramer acetate is an immunomodulator medication currently used to treat multiple sclerosis. The global Glatiramer Acetate market was valued at US$ 1072 million in 2023 and is anticipated to reach US$ 597.1 million by 2030, witnessing a CAGR of -6.8% .....
SynopsisExenatide is a medication used to treat diabetes mellitus type 2. The global Exenatide Drugs market was valued at US$ 284 million in 2023 and is anticipated to reach US$ 167.8 million by 2030, witnessing a CAGR of -6.8% during the forecast period 2024-20.....
SynopsisSomatostatin is one kind of hormone. It is widely distributed throughout the body, especially in the hypothalamus and pancreas. It also acts as an important regulator of endocrine and nervous system function by inhibiting the secretion of several other hormone.....
SynopsisSomatostatin is one kind of hormone. It is widely distributed throughout the body, especially in the hypothalamus and pancreas. It also acts as an important regulator of endocrine and nervous system function by inhibiting the secretion of several other hormone.....
SynopsisSomatostatin is one kind of hormone. It is widely distributed throughout the body, especially in the hypothalamus and pancreas. It also acts as an important regulator of endocrine and nervous system function by inhibiting the secretion of several other hormone.....
SynopsisObeticholic acid is a semi-synthetic bile acid analogue which has the chemical structure 6α-ethyl-chenodeoxycholic acid. The global Ocaliva market was valued at US$ 309 million in 2023 and is anticipated to reach US$ 240.4 million by 2030, witnessing a C.....
SynopsisObeticholic acid is a semi-synthetic bile acid analogue which has the chemical structure 6α-ethyl-chenodeoxycholic acid. The global Obeticholic Acid Drug market was valued at US$ 309 million in 2023 and is anticipated to reach US$ 240.4 million by 2030, .....
SynopsisLuteinizing Hormone-releasing Hormone is a releasing hormone responsible for the release of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) from the anterior pituitary. The global Luteinizing Hormone-releasing Hormone Analogs market was .....
